Description
NSE temporarily suspends trading in 6 UTI Annual Interval Fund units effective September 8, 2025 due to interval scheme provisions.
Summary
NSE has announced the temporary suspension of trading in 6 UTI Annual Interval Fund units effective September 8, 2025, following closing hours on September 5, 2025. The suspension is implemented under Regulation 3.1.2 of NSE Capital Market Trading Regulations due to interval scheme provisions.
Key Points
- 6 UTI Annual Interval Fund units will be suspended from trading
- Suspension effective from September 8, 2025
- Last trading day: September 5, 2025 (until closing hours)
- Suspension reason: Interval scheme provisions
- Trading may resume subject to AMC confirmation post closure of Specified Transaction Period (STP)
Regulatory Changes
Implementation of Regulation 3.1.2 of the National Stock Exchange (Capital Market) Trading Regulations Part A for interval scheme-related trading suspensions.
Compliance Requirements
- Members must cease trading in the specified UTI Annual Interval Fund units from September 8, 2025
- Asset Management Company (UTI) must confirm scheme continuation post STP closure for trading resumption
Important Dates
- September 5, 2025: Last trading day (until closing hours)
- September 8, 2025: Trading suspension effective date
- TBD: Potential resumption date subject to AMC confirmation
Impact Assessment
Limited market impact as suspension affects specific mutual fund units under interval scheme provisions. Normal operational procedure for interval funds where trading is periodically suspended. Investors in these funds should be aware of the temporary illiquidity during the suspension period.
Impact Justification
Affects specific mutual fund units with limited market impact due to interval scheme nature